CA49248/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1994	1
1995	3
1996	2
1997	1
1998	7
1999	4
2000	2
2001	4
2002	4
2003	3
2004	2
2005	4
2006	8
2007	4
2008	4
2009	3
2010	4
2011	2
2012	1
2013	4
2014	2
2021	0

1

Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Kumar S. Kumar S. Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):115-31. doi: 10.1517/17425250903431040. Expert Opin Drug Metab Toxicol. 2010. PMID: 20064075 Free PMC article. Review.

2

Harnessing apoptosis for improved anticancer gene therapy.

Waxman DJ, Schwartz PS. Waxman DJ, et al. Cancer Res. 2003 Dec 15;63(24):8563-72. Cancer Res. 2003. PMID: 14695163 Free article. Review.

3

Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Ma J, Waxman DJ. Ma J, et al. Mol Cancer Ther. 2008 Dec;7(12):3670-84. doi: 10.1158/1535-7163.MCT-08-0715. Mol Cancer Ther. 2008. PMID: 19074844 Free PMC article. Review.

4

Antiangiogenesis enhances intratumoral drug retention.

Ma J, Chen CS, Blute T, Waxman DJ. Ma J, et al. Cancer Res. 2011 Apr 1;71(7):2675-85. doi: 10.1158/0008-5472.CAN-10-3242. Epub 2011 Mar 29. Cancer Res. 2011. PMID: 21447737 Free PMC article.

5

Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.

Chen L, Waxman DJ. Chen L, et al. Curr Pharm Des. 2002;8(15):1405-16. doi: 10.2174/1381612023394566. Curr Pharm Des. 2002. PMID: 12052216 Review.

6

Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.

Roy P, Waxman DJ. Roy P, et al. Toxicol In Vitro. 2006 Mar;20(2):176-86. doi: 10.1016/j.tiv.2005.06.046. Epub 2005 Nov 15. Toxicol In Vitro. 2006. PMID: 16293390 Review.

7

Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.

Waxman DJ, Chang TK. Waxman DJ, et al. Methods Mol Biol. 2006;320:91-6. doi: 10.1385/1-59259-998-2:91. Methods Mol Biol. 2006. PMID: 16719377

8

Cancer chemotherapy and drug metabolism.

Riddick DS, Lee C, Ramji S, Chinje EC, Cowen RL, Williams KJ, Patterson AV, Stratford IJ, Morrow CS, Townsend AJ, Jounaidi Y, Chen CS, Su T, Lu H, Schwartz PS, Waxman DJ. Riddick DS, et al. Drug Metab Dispos. 2005 Aug;33(8):1083-96. doi: 10.1124/dmd.105.004374. Drug Metab Dispos. 2005. PMID: 16049130

9

Cytochrome P450-based gene therapy for cancer treatment: from concept to the clinic.

Jounaidi Y. Jounaidi Y. Curr Drug Metab. 2002 Dec;3(6):609-22. doi: 10.2174/1389200023337027. Curr Drug Metab. 2002. PMID: 12369889 Review.

10

Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.

Swanson HI, Njar VC, Yu Z, Castro DJ, Gonzalez FJ, Williams DE, Huang Y, Kong AN, Doloff JC, Ma J, Waxman DJ, Scott EE. Swanson HI, et al. Drug Metab Dispos. 2010 Apr;38(4):539-44. doi: 10.1124/dmd.109.031351. Drug Metab Dispos. 2010. PMID: 20233842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results